Shiell AM - Search Results

1

Assessing the cost-effectiveness of treating chronic hepatitis C virus in people who inject drugs in Australia.

Visconti AJ, Doyle JS, Weir A, Shiell AM, Hellard ME. Visconti AJ, et al. Among authors: shiell am. J Gastroenterol Hepatol. 2013 Apr;28(4):707-16. doi: 10.1111/jgh.12041. J Gastroenterol Hepatol. 2013. PMID: 23173753

2

The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C.

Shiell A, Briggs A, Farrell GC. Shiell A, et al. Med J Aust. 1994 Mar 7;160(5):268-72. Med J Aust. 1994. PMID: 8107627

3

Hepatitis C: an economic evaluation of extended treatment with interferon.

Shiell A, Brown S, Farrell GC. Shiell A, et al. Med J Aust. 1999 Aug 16;171(4):189-93. doi: 10.5694/j.1326-5377.1999.tb123595.x. Med J Aust. 1999. PMID: 10494234

4

The cost-effectiveness of installing sidewalks to increase levels of transport-walking and health.

Gunn LD, Lee Y, Geelhoed E, Shiell A, Giles-Corti B. Gunn LD, et al. Prev Med. 2014 Oct;67:322-9. doi: 10.1016/j.ypmed.2014.07.041. Epub 2014 Aug 11. Prev Med. 2014. PMID: 25124280

5

The cost-effectiveness of a law banning the use of cellular phones by drivers.

Sperber D, Shiell A, Fyie K. Sperber D, et al. Health Econ. 2010 Oct;19(10):1212-25. doi: 10.1002/hec.1546. Health Econ. 2010. PMID: 19764069

6

A method for the inclusion of physical activity-related health benefits in cost-benefit analysis of built environment initiatives.

Zapata-Diomedi B, Gunn L, Giles-Corti B, Shiell A, Lennert Veerman J. Zapata-Diomedi B, et al. Prev Med. 2018 Jan;106:224-230. doi: 10.1016/j.ypmed.2017.11.009. Epub 2017 Nov 8. Prev Med. 2018. PMID: 29126917

7

Cost effectiveness of brief interventions for reducing alcohol consumption.

Wutzke SE, Shiell A, Gomel MK, Conigrave KM. Wutzke SE, et al. Soc Sci Med. 2001 Mar;52(6):863-70. doi: 10.1016/s0277-9536(00)00189-1. Soc Sci Med. 2001. PMID: 11234861

8

Cost-effectiveness of investing in sidewalks as a means of increasing physical activity: a RESIDE modelling study.

Veerman JL, Zapata-Diomedi B, Gunn L, McCormack GR, Cobiac LJ, Mantilla Herrera AM, Giles-Corti B, Shiell A. Veerman JL, et al. Among authors: shiell a. BMJ Open. 2016 Sep 20;6(9):e011617. doi: 10.1136/bmjopen-2016-011617. BMJ Open. 2016. PMID: 27650762 Free PMC article.

9

The cost of hepatitis C and the cost-effectiveness of its prevention.

Shiell A, Law MG. Shiell A, et al. Health Policy. 2001 Nov;58(2):121-31. doi: 10.1016/s0168-8510(01)00159-2. Health Policy. 2001. PMID: 11551662

10

Interferon-alpha in hepatitis C. Dosage, costs and benefits.

Briggs A, Shiell A. Briggs A, et al. Pharmacoeconomics. 1996 Sep;10(3):205-9. doi: 10.2165/00019053-199610030-00002. Pharmacoeconomics. 1996. PMID: 10163569 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters